Industry: Medical Devices & Consumables
Published Date: 2026-01-08
Pages: 110 Pages
Report ld: 5595768
Request Sample
Customized Report
Biosupplements Containing Antibiotics Market Size(US$)

CAGR 2026-2032
6.0%
Market Size,2032
USD 840
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Biosupplements Containing Antibiotics market was valued at US$ 562 million in 2025 and is anticipated to reach US$ 840 million by 2032, at a CAGR of 6.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Biosupplements Containing Antibiotics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Antibiotic-containing biological patch is a specially treated biological material, usually derived from biological tissue, with antibiotics added during its preparation process, combining the properties of biological patch and antibiotics.
The North American market for Biosupplements Containing Antibiotics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Biosupplements Containing Antibiotics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Biosupplements Containing Antibiotics include Cook Biotech, LeMaitre, Medtronic, B. Braun, Smith & Nephew, Lamed, Braile Biomédica, Balancemed, KingstronBio, ZH-Bio., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Biosupplements Containing Antibiotics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biosupplements Containing Antibiotics. The Biosupplements Containing Antibiotics market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Biosupplements Containing Antibiotics market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Biosupplements Containing Antibiotics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Biosupplements Containing Antibiotics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Biosupplements Containing Antibiotics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Biosupplements Containing Antibiotics Market Overview
1.1 Product Definition
1.2 Biosupplements Containing Antibiotics by Type
1.2.1 Global Biosupplements Containing Antibiotics Market Value by Type: 2025 vs 2032
1.2.2 Composite Basement Membrane Biological Patch
1.2.3 Biological Hernia Repair Patch
1.2.4 Others
1.3 Biosupplements Containing Antibiotics by Application
1.3.1 Global Biosupplements Containing Antibiotics Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Ctlinic
1.3.4 Others
1.4 Global Biosupplements Containing Antibiotics Market Size Estimates and Forecasts
1.4.1 Global Biosupplements Containing Antibiotics Revenue 2021–2032
1.4.2 Global Biosupplements Containing Antibiotics Sales 2021–2032
1.4.3 Global Biosupplements Containing Antibiotics Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Biosupplements Containing Antibiotics Market Competition by Manufacturers
2.1 Global Biosupplements Containing Antibiotics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Biosupplements Containing Antibiotics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Biosupplements Containing Antibiotics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Biosupplements Containing Antibiotics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Biosupplements Containing Antibiotics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Biosupplements Containing Antibiotics, Product Types and Applications
2.7 Global Key Manufacturers of Biosupplements Containing Antibiotics, Date of Entry into the Industry
2.8 Global Biosupplements Containing Antibiotics Market Competitive Situation and Trends
2.8.1 Global Biosupplements Containing Antibiotics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Biosupplements Containing Antibiotics Players Market Share by Revenue
2.8.3 Global Biosupplements Containing Antibiotics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biosupplements Containing Antibiotics Market Scenario by Region
3.1 Global Biosupplements Containing Antibiotics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Biosupplements Containing Antibiotics Sales by Region: 2021–2032
3.2.1 Global Biosupplements Containing Antibiotics Sales by Region: 2021–2026
3.2.2 Global Biosupplements Containing Antibiotics Sales by Region: 2027–2032
3.3 Global Biosupplements Containing Antibiotics Revenue by Region: 2021–2032
3.3.1 Global Biosupplements Containing Antibiotics Revenue by Region: 2021–2026
3.3.2 Global Biosupplements Containing Antibiotics Revenue by Region: 2027–2032
3.4 North America Biosupplements Containing Antibiotics Market Facts & Figures by Country
3.4.1 North America Biosupplements Containing Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Biosupplements Containing Antibiotics Sales by Country (2021–2032)
3.4.3 North America Biosupplements Containing Antibiotics Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biosupplements Containing Antibiotics Market Facts & Figures by Country
3.5.1 Europe Biosupplements Containing Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Biosupplements Containing Antibiotics Sales by Country (2021–2032)
3.5.3 Europe Biosupplements Containing Antibiotics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biosupplements Containing Antibiotics Market Facts & Figures by Region
3.6.1 Asia Pacific Biosupplements Containing Antibiotics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Biosupplements Containing Antibiotics Sales by Region (2021–2032)
3.6.3 Asia Pacific Biosupplements Containing Antibiotics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biosupplements Containing Antibiotics Market Facts & Figures by Country
3.7.1 Latin America Biosupplements Containing Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Biosupplements Containing Antibiotics Sales by Country (2021–2032)
3.7.3 Latin America Biosupplements Containing Antibiotics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Biosupplements Containing Antibiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Biosupplements Containing Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Biosupplements Containing Antibiotics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Biosupplements Containing Antibiotics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biosupplements Containing Antibiotics Sales by Type (2021–2032)
4.1.1 Global Biosupplements Containing Antibiotics Sales by Type (2021–2026)
4.1.2 Global Biosupplements Containing Antibiotics Sales by Type (2027–2032)
4.1.3 Global Biosupplements Containing Antibiotics Sales Market Share by Type (2021–2032)
4.2 Global Biosupplements Containing Antibiotics Revenue by Type (2021–2032)
4.2.1 Global Biosupplements Containing Antibiotics Revenue by Type (2021–2026)
4.2.2 Global Biosupplements Containing Antibiotics Revenue by Type (2027–2032)
4.2.3 Global Biosupplements Containing Antibiotics Revenue Market Share by Type (2021–2032)
4.3 Global Biosupplements Containing Antibiotics Price by Type (2021–2032)
5 Segment by Application
5.1 Global Biosupplements Containing Antibiotics Sales by Application (2021–2032)
5.1.1 Global Biosupplements Containing Antibiotics Sales by Application (2021–2026)
5.1.2 Global Biosupplements Containing Antibiotics Sales by Application (2027–2032)
5.1.3 Global Biosupplements Containing Antibiotics Sales Market Share by Application (2021–2032)
5.2 Global Biosupplements Containing Antibiotics Revenue by Application (2021–2032)
5.2.1 Global Biosupplements Containing Antibiotics Revenue by Application (2021–2026)
5.2.2 Global Biosupplements Containing Antibiotics Revenue by Application (2027–2032)
5.2.3 Global Biosupplements Containing Antibiotics Revenue Market Share by Application (2021–2032)
5.3 Global Biosupplements Containing Antibiotics Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Cook Biotech
6.1.1 Cook Biotech Company Information
6.1.2 Cook Biotech Description and Business Overview
6.1.3 Cook Biotech Biosupplements Containing Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Cook Biotech Biosupplements Containing Antibiotics Product Portfolio
6.1.5 Cook Biotech Recent Developments/Updates
6.2 LeMaitre
6.2.1 LeMaitre Company Information
6.2.2 LeMaitre Description and Business Overview
6.2.3 LeMaitre Biosupplements Containing Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 LeMaitre Biosupplements Containing Antibiotics Product Portfolio
6.2.5 LeMaitre Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Biosupplements Containing Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Biosupplements Containing Antibiotics Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 B. Braun
6.4.1 B. Braun Company Information
6.4.2 B. Braun Description and Business Overview
6.4.3 B. Braun Biosupplements Containing Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 B. Braun Biosupplements Containing Antibiotics Product Portfolio
6.4.5 B. Braun Recent Developments/Updates
6.5 Smith & Nephew
6.5.1 Smith & Nephew Company Information
6.5.2 Smith & Nephew Description and Business Overview
6.5.3 Smith & Nephew Biosupplements Containing Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Smith & Nephew Biosupplements Containing Antibiotics Product Portfolio
6.5.5 Smith & Nephew Recent Developments/Updates
6.6 Lamed
6.6.1 Lamed Company Information
6.6.2 Lamed Description and Business Overview
6.6.3 Lamed Biosupplements Containing Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Lamed Biosupplements Containing Antibiotics Product Portfolio
6.6.5 Lamed Recent Developments/Updates
6.7 Braile Biomédica
6.7.1 Braile Biomédica Company Information
6.7.2 Braile Biomédica Description and Business Overview
6.7.3 Braile Biomédica Biosupplements Containing Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Braile Biomédica Biosupplements Containing Antibiotics Product Portfolio
6.7.5 Braile Biomédica Recent Developments/Updates
6.8 Balancemed
6.8.1 Balancemed Company Information
6.8.2 Balancemed Description and Business Overview
6.8.3 Balancemed Biosupplements Containing Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Balancemed Biosupplements Containing Antibiotics Product Portfolio
6.8.5 Balancemed Recent Developments/Updates
6.9 KingstronBio
6.9.1 KingstronBio Company Information
6.9.2 KingstronBio Description and Business Overview
6.9.3 KingstronBio Biosupplements Containing Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 KingstronBio Biosupplements Containing Antibiotics Product Portfolio
6.9.5 KingstronBio Recent Developments/Updates
6.10 ZH-Bio.
6.10.1 ZH-Bio. Company Information
6.10.2 ZH-Bio. Description and Business Overview
6.10.3 ZH-Bio. Biosupplements Containing Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 ZH-Bio. Biosupplements Containing Antibiotics Product Portfolio
6.10.5 ZH-Bio. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biosupplements Containing Antibiotics Industry Chain Analysis
7.2 Biosupplements Containing Antibiotics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biosupplements Containing Antibiotics Production Mode & Process Analysis
7.4 Biosupplements Containing Antibiotics Sales and Marketing
7.4.1 Biosupplements Containing Antibiotics Sales Channels
7.4.2 Biosupplements Containing Antibiotics Distributors
7.5 Biosupplements Containing Antibiotics Customer Analysis
8 Biosupplements Containing Antibiotics Market Dynamics
8.1 Biosupplements Containing Antibiotics Industry Trends
8.2 Biosupplements Containing Antibiotics Market Drivers
8.3 Biosupplements Containing Antibiotics Market Challenges
8.4 Biosupplements Containing Antibiotics Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Biosupplements Containing Antibiotics market is projected to grow from US$ 562 million in 2025 to US$ 840 million by 2032, at a CAGR of 6.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 146
USD 4900.00
(Single User License)
The global Biosupplements Containing Antibiotics market size was US$ 562 million in 2025 and is forecast to reach a readjusted size of US$ 840 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 79
USD 4250.00
(Single User License)
The global market for Biosupplements Containing Antibiotics was estimated to be worth US$ 562 million in 2025 and is projected to reach US$ 840 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 95
USD 3950.00
(Single User License)
The global Biosupplements Containing Antibiotics market size was US$ 533 million in 2024 and is forecast to a readjusted size of US$ 797 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 78
USD 4250.00
(Single User License)
The global Biosupplements Containing Antibiotics market is projected to grow from US$ 533 million in 2024 to US$ 797 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 149
USD 4900.00
(Single User License)
The global market for Biosupplements Containing Antibiotics was estimated to be worth US$ 533 million in 2024 and is forecast to a readjusted size of US$ 797 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 105
USD 3950.00
(Single User License)
The global market for Biosupplements Containing Antibiotics was valued at US$ 533 million in the year 2024 and is projected to reach a revised size of US$ 797 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published Date: 2025-03-10
Pages: 80
USD 2900.00
(Single User License)
Valued at US$ 533 million in 2024, the global Biosupplements Containing Antibiotics market is forecast to reach US$ 756 million by 2030, at a CAGR of 6.0% during the forecast period.
Published Date: 2024-11-29
Pages: 132
USD 4900.00
(Single User License)
The global Biosupplements Containing Antibiotics revenue was US$ 521 million in 2023 and is forecast to a readjusted size of US$ 756 million by 2030 with a CAGR of 6.0% during the review period (2024-2030).
Published Date: 2024-11-29
Pages: 104
USD 4350.00
(Single User License)
The global market for Biosupplements Containing Antibiotics was estimated to be worth US$ 521 million in 2023 and is forecast to a readjusted size of US$ 756 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030.
Published Date: 2024-11-29
Pages: 107
USD 3950.00
(Single User License)
The global Biosupplements Containing Antibiotics market is projected to grow from US$ 562 million in 2025 to US$ 840 million by 2032, at a CAGR of 6.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 146
The global Biosupplements Containing Antibiotics market size was US$ 562 million in 2025 and is forecast to reach a readjusted size of US$ 840 million by 2032 with a CAGR of 6.0% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 79
The global market for Biosupplements Containing Antibiotics was estimated to be worth US$ 562 million in 2025 and is projected to reach US$ 840 million, growing at a CAGR of 6.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 95
The global Biosupplements Containing Antibiotics market size was US$ 533 million in 2024 and is forecast to a readjusted size of US$ 797 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 78
The global Biosupplements Containing Antibiotics market is projected to grow from US$ 533 million in 2024 to US$ 797 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 149
The global market for Biosupplements Containing Antibiotics was estimated to be worth US$ 533 million in 2024 and is forecast to a readjusted size of US$ 797 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 105
The global market for Biosupplements Containing Antibiotics was valued at US$ 533 million in the year 2024 and is projected to reach a revised size of US$ 797 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-03-10
Pages: 80
Valued at US$ 533 million in 2024, the global Biosupplements Containing Antibiotics market is forecast to reach US$ 756 million by 2030, at a CAGR of 6.0% during the forecast period.
Published: 2024-11-29
Pages: 132
The global Biosupplements Containing Antibiotics revenue was US$ 521 million in 2023 and is forecast to a readjusted size of US$ 756 million by 2030 with a CAGR of 6.0% during the review period (2024-2030).
Published: 2024-11-29
Pages: 104
The global market for Biosupplements Containing Antibiotics was estimated to be worth US$ 521 million in 2023 and is forecast to a readjusted size of US$ 756 million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030.
Published: 2024-11-29
Pages: 107
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now